Value of almonds in heart health, beyond cholesterol, confirmed by new research

13 April 2008

Research presented at the International Experimental Biology Meeting held in San Diego, USA, this month provides insights as to why almonds may help reduce the risk of heart disease beyond their already-reported role in lowering cholesterol

This research highlights a number of reasons that these nuts, beyond their cholesterol-lowering effect, play an integral role in heart health. Additionally, new research shows they even have potential to improve gut health - indicating that almonds are a simple snack choice which can make a healthy difference.

Two new studies provide evidence to support the cholesterol-lowering effects of almonds. The first examined the long-term effects of the Portfolio Eating Plan, a dietary approach to lowering cholesterol that combines a number of heart-healthy foods such as almonds and soy in the same diet. After three years, subjects who closely followed the approach (greater than 75% compliance) reduced their low-density lipoprotein, or "bad" cholesterol levels, by an average of 24% - a significant and clinically meaningful decline.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight